Syremis Therapeutics
Tel Aviv
About Syremis Therapeutics
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $165.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: syremis.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Mental Health, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/syremis-therapeutics-122621 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.